Richard Maziarz: Where We Are and Where Cell Therapy Is Going?
Richard Maziarz, Medical Director, Blood and Marrow Transplant, Cellular Therapy Program at Oregon Health and Science University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Transplantation and Cellular Therapy, adding:
”Where we are, where we are going?
That was the message delivered during the opening session at the Tandem meetings 2026: A summary of the CIBMTR/EBMT/ASTCT collaborative has just been published.
The work ahead is daunting but the future looks bright for cell therapy clinical care delivery.”
Title: Challenges with expansion of cell and gene therapy: A call for system-level action
Authors: Jeffery J. Auletta, Alvaro Urbano-Ispizua, Richard T. Maziarz, Anna Sureda, Sumithra Vasu, David L. Porter
Stay updated wih Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?